Teva Pharmaceutical Industries


Teva Launches Two Digital Inhalers For Asthma Patients

Teva Pharmaceutical Industries launched two new digital inhalers AirDuo Digihaler and ArmonAir Digihaler in the US for patients with Asthma. With these two …

Stock Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and privately-held Immuneering Corporation today announced that the companies have entered into an agreement in which Teva will …

Company Update (NYSE:TEVA): Teva Pharmaceuticals Industries Ltd (ADR) and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis Pain

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Xenon Pharmaceuticals Inc. reported top line results from the double-blind, placebo-controlled Phase 2b study designed to evaluate the safety …

Stock Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Active Biotech announced that the patient enrollment for the pivotal Phase III CONCERTO trial has been finalized, as well …

Stock Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Completes the Purchase of 4.61 Percent Interest in Mylan N.V.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that it has completed the purchase of 4.61 percent of all outstanding shares of Mylan N.

Company Update (NYSE:TEVA): Teva Pharmaceuticals Industries Ltd (ADR) Advances Pipeline of Movement Disorder Assets with Announcement of Data for Patients with Tardive Dyskinesia

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced positive top-line results from the pivotal clinical study Aim to Reduce Movements in TardiveDyskinesia (ARM-TD) designed to evaluate the efficacy of …

Stock Update (NYSE:TEVA): Teva Pharmaceuticals Industries Ltd (ADR) Announces FDA Acceptance of the Biologics License Application for Reslizumab

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced that the U.S.

Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Enhances ADHD Product Line with Generic INTUNIV® in the United States

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the launch of the generic equivalent to INTUNIV® (guanfacine) 1 mg, 2 mg, 3 mg, and 4 …

Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Announces Exclusive Launch of Generic Actonel® Tablets in the United States

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Actonel® (risedronate sodium) Tablets, 5 mg, 30 mg, and 35 …

Stock Update (NYSE:TEVA): Jack Osbourne and Teva Pharmaceutical Industries Ltd (ADR) Launch Enhanced You Don’t Know Jack About MS® Website Featuring New Multimedia Content

World Multiple Sclerosis Day, Jack Osbourne, in partnership with Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), kicked off the third year of the You Don’t …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts